|
시장보고서
상품코드
1652029
세계의 프로테이나제 K 시장 : 시장 규모, 점유율 및 동향, 업계 분석 - 형상별, 치료 영역별, 최종 사용자별, 지역별, 예측(2025-2034년)Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 세계의 프로테이나제 K 시장 규모는 2034년까지 108억 7,000만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
프로테이나제 K 시장의 성장은 유전자 연구, 진단 및 생명 공학에서 분자 생물학 도구 수요 증가로 이어지고 있습니다. 주요 촉진요인으로는 맞춤형 의료의 인기가 높아지고 차세대 시퀀싱(NGS) 및 중합 효소 연쇄반응(PCR) 기술의 채용 확대, DNA 및 RNA 추출에서 프로테이나제 K의 사용 확대 등이 있습니다.
프로테이나제 K 시장 기회는 의료 및 생명 공학의 발전이 수요를 촉진하는 아시아태평양을 중심으로 한 신흥 시장에 존재합니다. 안정성을 향상시킨 재조합형을 포함한 효소 생산에 있어서 기술 혁신이나 정밀의료에 대한 관심이 높아지는 등의 동향이 시장을 형성하고 있습니다. 전반적으로, 프로테이나제 K 시장 수요는 프로테이나제 K가 분자진단, 의약품 개발, 유전자 검사에 필수적이 됨에 따라 계속 확대될 것으로 예상됩니다.
프로테이나제 K 시장 : 분석 개요
보존 기간이 길고 연구 용도에 널리 사용되고 있기 때문에 분말 부문이 프로테이나제 K 시장 점유율을 독점하고 있습니다. 액제는 진단이나 임상 현장에서의 편리성에 의해 급성장을 이루고 있습니다.
치료 분야별로는 감염증 분야가 진단 툴 수요 증가에 견인되어 최대 점유율을 차지하고 있습니다. 암 분야는 개별화 암 치료에 있어서 유전체 해석의 필요성에 추진되어 가장 급성장하고 있는 분야입니다.
최종 사용자별로는 바이오 테크놀로지 기업이 의약품 개발이나 연구에 프로테이나아제 K를 폭넓게 응용하고 있기 때문에 최대 시장 점유율을 차지하고 있습니다. CRO(의약품 개발 업무 위탁 기관) 부문은 연구 활동의 아웃소싱 증가로 인해 가장 높은 성장률을 기록하고 있습니다.
북미는 고급 의료 인프라와 분자 진단의 왕성한 수요에 견인되어 프로테이나제 K 시장의 수익 점유율을 독점하고 있습니다. 그러나 중국과 인도 등 국가에서 생명공학과 의료의 급속한 진보에 힘입어 아시아태평양이 가장 높은 성장률을 보이고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 프로테이나제 K 시장 인사이트
- 시장 현황
- 프로테이나제 K 시장 역학
- 성장 촉진요인 및 기회
- 분자 진단에 있어서 채용 증가
- 효소 생산 기술의 진보
- 정밀 의료에 대한 주목의 고조
- 억제요인 및 과제
- 높은 생산 비용 및 시약 비용
- 성장 촉진요인 및 기회
- PESTLE 분석
- 프로테이나제 K 시장 동향 : 최종 사용자별
- 밸류체인 분석
제5장 세계의 프로테이나제 K 시장 : 형상별
- 주요 조사 결과
- 서문
- 분말
- 액체
제6장 세계의 프로테이나제 K 시장 : 치료 영역별
- 주요 조사 결과
- 서문
- 감염증
- 당뇨병
- 종양
- 심장병
- 기타 치료 영역
제7장 세계의 프로테이나제 K 시장 : 최종 사용자별
- 주요 조사 결과
- 서문
- CRO(의약품 개발 업무 수탁 기관)
- 학술기관
- 바이오테크놀러지 기업
- 진단 실험실
제8장 세계의 프로테이나제 K 시장 : 지역별
- 주요 조사 결과
- 서문
- 프로테이나제 K 시장의 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 형상별(2020-2034년)
- 북미 : 치료 영역별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 형상별(2020-2034년)
- 유럽 : 치료 영역별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 형상별(2020-2034년)
- 아시아태평양 : 치료 영역별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 형상별(2020-2034년)
- 중동 및 아프리카 : 치료 영역별(2020-2034년)
- 중동 및 아프리카 : 최종 사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 형상별(2020-2034년)
- 라틴아메리카 : 치료 영역별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴, 협업, 합의 및 공개
제10장 기업 프로파일
- Thermo Fisher Scientific
- Sigma-Aldrich
- New England Biolabs c
- Roche
- QIAGEN
- Promega Corporation
- Bio-Rad Laboratories
- Abcam
- Merck Millipore
- VWR International
- Takara Bio
- Creative Enzymes
- Biotech Biochemicals
- FUJIFILM Wako Chemicals
- Integrated DNA Technologies
The global Proteinase K market size is expected to reach USD 10.87 billion by 2034, according to a new study by Polaris Market Research. The report "Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The Proteinase K market growth is driven by the increasing demand for molecular biology tools in genetic research, diagnostics, and biotechnology. Key drivers include the rising popularity of personalized medicine, growing adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies, and the expanding use of Proteinase K in DNA and RNA extraction.
Proteinase K market opportunities exist in emerging markets, particularly in Asia Pacific, where advancements in healthcare and biotechnology are fostering demand. Trends such as innovations in enzyme production, including recombinant variants with improved stability, and the growing focus on precision medicine are shaping the market. Overall, the Proteinase K market demand is expected to continue expanding as Proteinase K becomes more essential in molecular diagnostics, drug development, and genetic testing.
Proteinase K Market Report Highlights:
Based on form. the powder segment dominates the Proteinase K market share due to its longer shelf life and widespread use in research applications. The liquid segment is witnessing the fastest growth, driven by its convenience in diagnostic and clinical settings.
By therapeutic area, the infectious diseases segment holds the largest share, driven by the increasing demand for diagnostic tools. The oncology segment is the fastest-growing segment, fueled by the need for genomic analysis in personalized cancer therapies.
The biotechnology companies segment, by end user, holds the largest market share due to their broad application of Proteinase K in drug development and research. The contract research organizations (CROs) segment is registering the highest growth rate due to the increasing outsourcing of research activities.
North America dominates the Proteinase K market revenue share, driven by advanced healthcare infrastructure and strong demand in molecular diagnostics. However, Asia Pacific is the highest-growing region, supported by rapid advancements in biotechnology and healthcare in countries such as China and India.
Polaris Market Research has segmented the Proteinase K market report on the basis of form, therapeutic area, end user, and region:
By Form Outlook (Revenue - USD Billion, 2020-2034)
- Powder
- Liquid
By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Other Therapeutic Areas
By End User Outlook (Revenue - USD Billion, 2020-2034)
- Contract Research Organization
- Academic Institutes
- Biotechnology Companies
- Diagnostic Laboratories
By Regional Outlook (Revenue - USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Proteinase K Market Insights
- 4.1. Proteinase K Market - Market Snapshot
- 4.2. Proteinase K Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Adoption in Molecular Diagnostics
- 4.2.1.2. Advancements in Enzyme Production Technology
- 4.2.1.3. Rising Focus on Precision Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Production and Reagents
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Proteinase K Market End User Trends
- 4.6. Value Chain Analysis
5. Global Proteinase K Market, by Form
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 5.3. Powder
- 5.3.1. Global Proteinase K Market, by Powder, by Region, 2020-2034 (USD Billion)
- 5.4. Liquid
- 5.4.1. Global Proteinase K Market, by Liquid, by Region, 2020-2034 (USD Billion)
6. Global Proteinase K Market, by Therapeutic Area
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 6.3. Infectious Diseases
- 6.3.1. Global Proteinase K Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
- 6.4. Diabetes
- 6.4.1. Global Proteinase K Market, by Diabetes, by Region, 2020-2034 (USD Billion)
- 6.5. Oncology
- 6.5.1. Global Proteinase K Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 6.6. Cardiology
- 6.6.1. Global Proteinase K Market, by Cardiology, by Region, 2020-2034 (USD Billion)
- 6.7. Other Therapeutic Areas
- 6.7.1. Global Proteinase K Market, by Other Therapeutic Areas, by Region, 2020-2034 (USD Billion)
7. Global Proteinase K Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 7.3. Contract Research Organization
- 7.3.1. Global Proteinase K Market, by Contract Research Organization, by Region, 2020-2034 (USD Billion)
- 7.4. Academic Institutes
- 7.4.1. Global Proteinase K Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
- 7.5. Biotechnology Companies
- 7.5.1. Global Proteinase K Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 7.6. Diagnostic Laboratories
- 7.6.1. Global Proteinase K Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
8. Global Proteinase K Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Proteinase K Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Proteinase K Market - North America
- 8.3.1. North America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.3.2. North America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.3.3. North America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Proteinase K Market - U.S.
- 8.3.4.1. U.S.: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Proteinase K Market - Canada
- 8.3.5.1. Canada: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4. Proteinase K Market - Europe
- 8.4.1. Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.2. Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.3. Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Proteinase K Market - UK
- 8.4.4.1. UK: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Proteinase K Market - France
- 8.4.5.1. France: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.5.2. France: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.5.3. France: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Proteinase K Market - Germany
- 8.4.6.1. Germany: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Proteinase K Market - Italy
- 8.4.7.1. Italy: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Proteinase K Market - Spain
- 8.4.8.1. Spain: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Proteinase K Market - Netherlands
- 8.4.9.1. Netherlands: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Proteinase K Market - Russia
- 8.4.10.1. Russia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Proteinase K Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5. Proteinase K Market - Asia Pacific
- 8.5.1. Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Proteinase K Market - China
- 8.5.4.1. China: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.4.2. China: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.4.3. China: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Proteinase K Market - India
- 8.5.5.1. India: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.5.2. India: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.5.3. India: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Proteinase K Market - Malaysia
- 8.5.6.1. Malaysia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Proteinase K Market - Japan
- 8.5.7.1. Japan: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Proteinase K Market - Indonesia
- 8.5.8.1. Indonesia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Proteinase K Market - South Korea
- 8.5.9.1. South Korea: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Proteinase K Market - Australia
- 8.5.10.1. Australia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Proteinase K Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6. Proteinase K Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Proteinase K Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Proteinase K Market - UAE
- 8.6.5.1. UAE: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Proteinase K Market - Israel
- 8.6.6.1. Israel: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Proteinase K Market - South Africa
- 8.6.7.1. South Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Proteinase K Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7. Proteinase K Market - Latin America
- 8.7.1. Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Proteinase K Market - Mexico
- 8.7.4.1. Mexico: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Proteinase K Market - Brazil
- 8.7.5.1. Brazil: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Proteinase K Market - Argentina
- 8.7.6.1. Argentina: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Proteinase K Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Thermo Fisher Scientific
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Sigma-Aldrich
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. New England Biolabs c
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Roche
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. QIAGEN
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Bio-Rad Laboratories
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Abcam
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Merck Millipore
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. VWR International
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Takara Bio
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Creative Enzymes
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Biotech Biochemicals
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. FUJIFILM Wako Chemicals
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Integrated DNA Technologies
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
비교리스트